Effects of MPH-OROS on the Organizational, Time Management, and Planning Behaviors of Children With ADHD

Abikoff, Howard; Nissley-Tsiopinis, Jenelle; Gallagher, Richard; Zambenedetti, Maurizio; Seyffert, Michael; Boorady, Roy; McCarthy, John

doi:10.1097/chi.0b013e3181930626

Cited by 58 publications

(58 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Specifically, Pelham et al found that although stimulant medication improved immediate attention during the games, it did not affect actual performance or skills (1990). Similarly, Abikoff et al (2009) found that while methylphenidate improved aspects of organization, time management, and planning in children with ADHD, it did not eliminate deficits to the point of normalization. In fact, over 60% of participants continued to exhibit significant deficits in these areas while on medication (Abikoff et al, 2009).…”

Section: Discussionmentioning

confidence: 94%

“…Similarly, Abikoff et al (2009) found that while methylphenidate improved aspects of organization, time management, and planning in children with ADHD, it did not eliminate deficits to the point of normalization. In fact, over 60% of participants continued to exhibit significant deficits in these areas while on medication (Abikoff et al, 2009). Thus, medication may be a necessary, but not sufficient method for improving complex skill performance.…”

Section: Discussionmentioning

confidence: 94%

See 1 more Smart Citation

The Effects of Stimulant Medication on the Online Story Narrations of Children with ADHD

Derefinko

Bailey

Milich

et al. 2009

School Mental Health

View full text Add to dashboard Cite

The current study investigated the inclusion of goal-based story events in the online story narrations of children with attention deficit hyperactivity disorder (ADHD), as compared with their peers, and explored the effect of stimulant medication on the narrations in children with ADHD. Children completed a narration task on two separate occasions. Children with ADHD (n = 17) completed one narration on medication and the other one on placebo. Results indicated that narrations of comparison children (n = 25) were significantly more likely than narrations of children with ADHD to include the story's positive outcome, completion of the story's overall goal, and specific attempts linked to the goal. Children with ADHD included a larger total number of clauses in their narrations when on stimulant medication than when on placebo, but medication showed no significant effects for any other variables. Results indicate that stimulant medication may not be effective at reducing goal-based story comprehension deficits in children with ADHD.

show abstract

Section: Discussionmentioning

confidence: 94%

Section: Discussionmentioning

confidence: 94%

The Effects of Stimulant Medication on the Online Story Narrations of Children with ADHD

Derefinko

Bailey

Milich

et al. 2009

School Mental Health

View full text Add to dashboard Cite

show abstract

“…Efficacy of osmotic-release oral system methylphenidate has been documented with different scales like the children Inattention and Overactivity With Aggression (IOWA) Conners in both inattentive-impulsive-overactive and oppositional-defiant subscales, 24 physician-rated Clinical Global ImpressionImprovement scale, 24 parent-rated Global Efficacy Assessment scale, 24 Conners' Parents Rating Scale, 25 Children's Global Assessment Scale, 25 Inventory for Assessment of Quality of Life in Children and Adolescents, 25 Young's Internet Addiction Scale, 26 DuPaul's ADHD Rating Scale, 26 and parent and teacher versions of the Children's Organizational Skills Scale. 27 A positive improvement under osmotic-release oral system methylphenidate has also been reported on cognitive tasks such as the Rey complex figure test, digit span, Stroop color-word task, verbal fluency test and trail-making test, 28 Visual Continuous Performance Test, 26 X and O discrimination task, 29 and working memory tasks. 30 However, the main benefit of osmotic-release oral system methylphenidate is its fullday coverage (12 hours) with a single daily dose, and one should evaluate the importance of a treatment that covers not only school time but also takes other moments of life into account.…”

mentioning

confidence: 94%

Cognitive Improvement of Attention and Inhibition in the Late Afternoon in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Treated With Osmotic-Release Oral System Methylphenidate

et al. 2014

View full text Add to dashboard Cite

Long-acting medications have been developed and approved for use in the treatment of attention-deficit hyperactivity disorder (ADHD). These compounds are intended to optimize and maintain symptoms control throughout the day. We tested prolonged effects of osmotic-release oral system methylphenidate on both attention and inhibition, in the late afternoon. A double-blind, randomized, placebo-controlled study was conducted in 36 boys (7-12 years) with ADHD and 40 typically developing children. The ADHD children received an individualized dose of placebo or osmotic-release oral system methylphenidate. They were tested about 8 hours after taking with 2 continuous performance tests (continuous performance test-X [CPT-X] and continuous performance test-AX [CPT-AX]) and a counting Stroop. A positive effect of osmotic-release oral system methylphenidate was present in CPT-AX with faster and less variable reaction times under osmotic-release oral system methylphenidate than under placebo, and no difference with typically developing children. In the counting Stroop, we found a decreased interference with osmotic-release oral system methylphenidate but no difference between children with ADHD under placebo and typically developing children.

show abstract

“…However, medications alone may represent insufficient treatment for many individuals with ADHD (Gualtieri & Johnson, 2008). At least one study has documented ongoing organizational and time management skill deficits in over half of a sample of children with ADHD despite effective medication management (Abikoff et al, 2009). Similarly, symptom improvements in adults with ADHD treated with medication may not necessarily translate to improved executive functioning skills (e.g., planning, organization, time management, task follow through) and desired improvements in adult role functioning.…”

mentioning

confidence: 96%

CBT Without Medications for Adult ADHD: An Open Pilot Study of Five Patients

Ramsay

Rostain

2011

J Cogn Psychother

View full text Add to dashboard Cite

Medications are considered the primary treatment for symptoms of adult attention-deficit/ hyperactivity disorder (ADHD), although medications alone may not produce sufficient functional improvements for many patients. Moreover, some adults with ADHD decline pharmacotherapy due to lack of response, side effects, medical contraindication, or personal choice. This article reports on the clinical outcomes of five adults with ADHD who completed cognitive behavioral therapy (CBT) without concurrent medication treatment. Nonparametric analysis of pretreatment and posttreatment clinical data indicated significant improvements on various measures of ADHD symptoms, overall functioning, depression, and anxiety. Although limited by the small sample size, the current pilot study provides preliminary evidence that CBT may be helpful for adults with ADHD who decline or are unable to take medications in cases in which their symptoms and impairments are relatively mild and uncomplicated. The limitations of this open pilot study and directions for future research also are discussed.

show abstract

Effects of MPH-OROS on the Organizational, Time Management, and Planning Behaviors of Children With ADHD

Cited by 58 publications

References 44 publications

The Effects of Stimulant Medication on the Online Story Narrations of Children with ADHD

The Effects of Stimulant Medication on the Online Story Narrations of Children with ADHD

Cognitive Improvement of Attention and Inhibition in the Late Afternoon in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Treated With Osmotic-Release Oral System Methylphenidate

CBT Without Medications for Adult ADHD: An Open Pilot Study of Five Patients

Contact Info

Product

Resources

About